Rezolute RZLT
NASDAQ RZLT
$4.01 -0.06 (-1.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Rezolute (RZLT) Accumulated Expenses (2020)

Updated

Rezolute (RZLT) posted Accumulated Expenses of $688,000 for fiscal Q1 2021 (quarter ended Sep 30, 2020), down 29.5% from the prior quarter.

Analysis

Rezolute (RZLT) Accumulated Expenses (2020) Analysis & Trends

At the end of FY2020 (ended Jun 30, 2020), Rezolute's Accumulated Expenses came in at $976,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn
10 Rezolute 392.37 Mn 392.37 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 688,000.00
Jun 30, 2020 976,000.00
API Access

Rezolute Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=RZLT&period=max&api_key=YOUR_API_KEY